Kedudukan dalam Saham
#26790
Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to... Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to developing innovative radiopharmaceutical treatments for various cancers. Its primary therapeutic agent is Radspherin, an alpha-emitting radiotherapeutic, which is currently undergoing investigation in two Phase 1/2a and one randomized Phase 2 clinical trials. This promising candidate is designed to target and treat malignancies that have metastasized to body cavities, specifically including the peritoneum.
Perubahan (1 hari)
-7.83%
Perubahan (1 tahun)
-26.06%
Perdagangan Oncoinvent ASA (ONCIN)
Harga ONCIN dengan permodalan pasaran b
Modal pasaran bagi Oncoinvent ASA(ONCIN)
Modal Pasaran: $37.55M
Sehingga August 2026, Oncoinvent ASA mempunyai modal pasaran sebanyak $37.55M. Ini menjadikan Oncoinvent ASA syarikat ke-26790th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Oncoinvent ASA dari 2017 hingga 2026
ONCIN berbanding dengan 5 teratas yang paling popular stocks
| Harga ONCIN |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.301T
|
+14,114,855.47%
|
|
|
|
|
$4.634T
|
+12,338,792.78%
|
|
|
|
|
$4.143T
|
+11,031,676.21%
|
|
|
|
|
$3.589T
|
+9,557,549.20%
|
|
|
|
|
$2.857T
|
+7,607,277.29%
|
